{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T21:23:04Z","timestamp":1694294584676},"reference-count":30,"publisher":"American Society of Clinical Oncology (ASCO)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCO"],"published-print":{"date-parts":[[2002,1,15]]},"abstract":"<jats:p> PURPOSE: We report the first large prospective study of children with myelodysplastic syndrome (MDS) and juvenile myelomonocytic leukemia (JMML) treated in a uniform fashion on Children\u2019s Cancer Group protocol 2891. <\/jats:p><jats:p> PATIENTS AND METHODS: Ninety children with JMML, various forms of MDS, or acute myeloid leukemia (AML) with antecedent MDS were treated with a five-drug induction regimen (standard or intensive timing). Patients achieving remission were allocated to allogeneic bone marrow transplantation (BMT) if a matched family donor was available. All other patients were randomized between autologous BMT and aggressive nonmyeloablative chemotherapy. Results were compared with patients with de novo AML. <\/jats:p><jats:p> RESULTS: Patients with JMML and refractory anemia (RA) or RA-excess blasts (RAEB) exhibited high induction failure rates and overall remission of 58% and 48%, respectively. Remission rates for patients with RAEB in transformation (RAEB-T) (69%) or antecedent MDS (81%) were similar to de novo AML (77%). Actuarial survival rates at 6 years were as follows: JMML, 31% \u00b1 26%; RA and RAEB, 29% \u00b1 16%; RAEB-T, 30% \u00b1 18%; antecedent MDS, 50% \u00b1 25%; and de novo AML, 45% \u00b1 3%. For patients achieving remission, long-term survivors were found in those receiving either allogeneic BMT or chemotherapy. The presence of monosomy 7 had no additional adverse effect on MDS and JMML. <\/jats:p><jats:p> CONCLUSION: Childhood subtypes of MDS and JMML represent distinct entities with distinct clinical outcomes. Children with a history of MDS who present with AML do well with AML-type therapy. Patients with RA or RAEB respond poorly to AML induction therapy. The optimum treatment for JMML remains unknown. <\/jats:p>","DOI":"10.1200\/jco.2002.20.2.434","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T07:59:20Z","timestamp":1487923160000},"page":"434-440","source":"Crossref","is-referenced-by-count":5,"title":["Prospective Study of 90 Children Requiring Treatment for Juvenile Myelomonocytic Leukemia or Myelodysplastic Syndrome: A Report From the Children\u2019s Cancer Group"],"prefix":"10.1200","volume":"20","author":[{"given":"William G.","family":"Woods","sequence":"first","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorothy R.","family":"Barnard","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todd A.","family":"Alonzo","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan D.","family":"Buckley","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan","family":"Kobrinsky","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane C.","family":"Arthur","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Sanders","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Neudorf","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Gold","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly J.","family":"Lange","sequence":"additional","affiliation":[{"name":"From the AFLAC Cancer Center, Emory University\/Children\u2019s Healthcare, Atlanta, GA; Izaak W. Killam Hospital for Children, Halifax, Nova Scotia; University of Southern California Keck School of Medicine, Los Angeles, CA; Roger Maris Cancer Center, Fargo, ND; National Cancer Institute, Bethesda, MD; Fred Hutchinson Cancer Research Center, Seattle, WA; Children\u2019s Hospital of Pittsburgh, Pittsburgh, PA; University of North Carolina, Chapel Hill, NC; and Children\u2019s Hospital of Philadelphia, Philadelphia, PA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"233","reference":[{"key":"R1-101765","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.tb08475.x"},{"key":"R2-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.2.479"},{"key":"R3-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V85.7.1742.bloodjournal8571742"},{"key":"R4-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1986.4.12.1857"},{"key":"R5-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1990.8.8.1424"},{"key":"R6-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1993.11.8.1448"},{"key":"R7-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.12.1960"},{"key":"R8-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V71.4.1144.1144"},{"key":"R9-101765","doi-asserted-by":"publisher","DOI":"10.3109\/10428199509051708"},{"key":"R10-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V88.1.358.358"},{"key":"R11-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1985.3.1.3"},{"key":"R12-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.12.4979.bloodjournal87124979"},{"key":"R13-101765","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(19900915)66:6<1106::AID-CNCR2820660605>3.0.CO;2-Y"},{"key":"R14-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.11.2367"},{"key":"R15-101765","doi-asserted-by":"crossref","unstructured":"Woods  WG,   Neudorf  S,   Gold  S,  et al:   A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation and aggressive chemotherapy in children with acute myeloid leukemia in remission:  A report from the Children\u2019s Cancer Group.   Blood 91:  56,2001\u201362,","DOI":"10.1182\/blood.V97.1.56"},{"key":"R16-101765","doi-asserted-by":"publisher","DOI":"10.2307\/2344317"},{"key":"R17-101765","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452"},{"key":"R19-101765","unstructured":"Head  DR:   Revised classification of acute myeloid leukemia.  Leukemia 10:  1826,1996\u20131831,"},{"key":"R20-101765","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.9.2486"},{"key":"R21-101765","doi-asserted-by":"crossref","unstructured":"Estey  E,   Thall  P,   Beran  M,  et al:   Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy.  Blood 8:  2969,1997\u20132977,","DOI":"10.1182\/blood.V90.8.2969"},{"key":"R22-101765","doi-asserted-by":"publisher","DOI":"10.1097\/00043426-198724000-00009"},{"key":"R23-101765","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400987"},{"key":"R24-101765","unstructured":"Hasle  H,   Kerndrup  G,   Yssing  M,  et al:   Intensive chemotherapy in childhood myelodysplastic syndrome:  A comparison with results in acute myeloid leukemia.   Leukemia 10:  1269,1996\u20131273,"},{"key":"R25-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V89.10.3864"},{"key":"R26-101765","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2087.x"},{"key":"R27-101765","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.4811022.x"},{"key":"R28-101765","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91268-1"},{"key":"R29-101765","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.2.459"},{"key":"R30-101765","doi-asserted-by":"crossref","unstructured":"Luna-Fineman  S,   Shannon  KM,   Lange  BJ:   Childhood monosomy 7:  Epidemiology, biology, and mechanistic implications.   Blood 8:  1985,1995\u20131999,","DOI":"10.1182\/blood.V85.8.1985.bloodjournal8581985"},{"key":"R31-101765","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199412223312503"}],"container-title":["Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ascopubs.org\/doi\/pdfdirect\/10.1200\/JCO.2002.20.2.434","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T21:54:09Z","timestamp":1653515649000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascopubs.org\/doi\/10.1200\/JCO.2002.20.2.434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,1,15]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,1,15]]}},"alternative-id":["10.1200\/JCO.2002.20.2.434"],"URL":"https:\/\/doi.org\/10.1200\/jco.2002.20.2.434","relation":{},"ISSN":["0732-183X","1527-7755"],"issn-type":[{"value":"0732-183X","type":"print"},{"value":"1527-7755","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,1,15]]}}}